| Serial Number | 98910459 |
| Word Mark | NOW WE CAN |
| Filing Date | Wednesday, December 18, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 9, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 9, 2025 |
| Goods and Services | Research, development, and design of pharmaceuticals and medicines for others; scientific research in the field of pharmaceutical and medicine design, discovery and development services for others; research and development of technology for others in the field of pharmaceuticals; research and development of technology for others in the field of computational biology; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development for others; collecting and analyzing complex biological data through the use of artificial intelligence, namely, data automation and collection service using proprietary software to evaluate, analyze and collect biological data for research and scientific purposes; computer assisted molecule design involving the use of artificial intelligence technology, namely, product design and development in the field of medicine; conducting scientific and pharmaceutical artificial intelligence research services for others to identify molecules and compounds for drug development, namely, scientific research in the field of pharmaceuticals; providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 18, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Generate Biomedicines, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 |
| Party Name | Generate Biomedicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 |
| Event Date | Event Description |
| Wednesday, December 18, 2024 | NEW APPLICATION ENTERED |
| Monday, February 3, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, February 3, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, February 3, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, June 5, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, December 18, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 12, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 4, 2025 | ASSIGNED TO EXAMINER |
| Monday, August 11, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 11, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 11, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, August 11, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 12, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, June 12, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, August 11, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, September 3, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, September 3, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 3, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, September 3, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, September 9, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 9, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |